Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment67
Advancement in transporter-oriented nanoplatforms for cancer therapy54
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma47
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances42
Post-transcriptional knockdown of BRCC3 via siRNA-loaded niosomes modulates autophagy and endoplasmic reticulum stress in rotenone-induced Parkinson’s Disease model35
Polymyxin B delivery systems: smart solutions for improved antibacterial activity and reduced toxicity34
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis33
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma31
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches31
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells31
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control28
Beyond drug delivery: nanoparticles as active modulators of immunometabolism for treating inflammatory diseases28
Correction28
Application of small interfering RNAs and drug combination for pancreatic cancer therapy26
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases26
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes26
Chitosan–β-glycerophosphate thermogelling microneedles for transdermal contraceptive delivery of levonorgestrel25
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer24
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer24
Emerging role of ferroptosis in diabetic retinopathy: a review24
Correction23
Engineered extracellular vesicle with RAGE-antagonist peptide for delivery of anti-miRNA155 oligonucleotides to inflammatory lung cells23
The role of MSC-derived exosomes in immune modulation and regenerative medicine23
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review23
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice23
0.096410989761353